secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2026-08-18T20:30:32+00:00
Accession:  0001493152-26-039023
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma appoints Carol L. Brosgart to board of directors
-----------------------------------------------------------------

- Carol L. Brosgart appointed as director effective August 12, 2026.
- No arrangements or understandings with other persons regarding her selection.
- No family relationships or related party transactions requiring disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000149315226039023/0001493152-26-039023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000149315226039023/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-039023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer